Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)

计划入组 30 人 · 首次发布于 2024 年 9 月 3 日

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

计划入组 30 人 · 首次发布于 2025 年 1 月 13 日

MAMI-RCT Study

计划入组 80 人

MMAI

LFM-A12

AAV-LF2

CHIANG MAI UNIVERSITY

Thailand

MAHARAJ NAKORN CHIANG MAI HOSPITAL

Thailand

FACULTY OF MEDICINE, CHIANG MAI UNIVERSITY

Thailand

Insilico Medicine and Liquid AI Launch Lightweight AI Model for On-Premise Drug Discovery

AI Biomarker Predicts Survival and Treatment Response in Oligometastatic Prostate Cancer

Seagen Secures $2.6B Deal with RemeGen for Novel HER2-Targeting Cancer Drug